{"id":"https://openalex.org/W4206018554","doi":"https://doi.org/10.1002/prp2.910","title":"Risk of genital and urinary tract infections associated with SGLT\u20102 inhibitors as an add\u2010on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea","display_name":"Risk of genital and urinary tract infections associated with SGLT\u20102 inhibitors as an add\u2010on therapy to metformin in patients with type 2 diabetes mellitus: A retrospective cohort study in Korea","publication_year":2022,"publication_date":"2022-01-10","ids":{"openalex":"https://openalex.org/W4206018554","doi":"https://doi.org/10.1002/prp2.910","pmid":"https://pubmed.ncbi.nlm.nih.gov/35005849","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8929338"},"language":"en","primary_location":{"id":"doi:10.1002/prp2.910","doi":"https://doi.org/10.1002/prp2.910","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.910","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.910","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.910","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033609046","display_name":"Hyeri Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hyeri Yang","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082314510","display_name":"Eunmi Choi","orcid":"https://orcid.org/0000-0002-8486-4222","observed_orcids":["https://orcid.org/0000-0002-8486-4222"]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Eunmi Choi","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":"https://orcid.org/0000-0002-8486-4222","affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Eunjun Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Eunjun Park","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088810764","display_name":"Eonji Na","orcid":"https://orcid.org/0009-0001-9778-2613","observed_orcids":["https://orcid.org/0009-0001-9778-2613"]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Eonji Na","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085705153","display_name":"Soo Youn Chung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Soo Youn Chung","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031585590","display_name":"Bong Gi Kim","orcid":"https://orcid.org/0000-0002-0965-1323","observed_orcids":["https://orcid.org/0000-0002-0965-1323"]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Bonggi Kim","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":"https://orcid.org/0000-0002-0965-1323","affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111995579","display_name":"Soon Young Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117935","display_name":"Korea Institute of Drug Safety and Risk Management","ror":"https://ror.org/02fsqa093","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117935"]}],"countries":["KR"],"is_corresponding":true,"raw_author_name":"Soon Young Han","raw_affiliation_strings":["Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Safety Information, Korea Institute of Drug Safety and Risk Management, Gyeonggi-do, Republic of Korea","institution_ids":["https://openalex.org/I4210117935"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5031585590","https://openalex.org/A5111995579"],"corresponding_institution_ids":["https://openalex.org/I4210117935"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":4.9811,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.96433349,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"e00910","last_page":"e00910"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9878000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/genital-tract-infection","display_name":"genital tract infection","score":0.8510000109672546},{"id":"https://openalex.org/keywords/urinary-tract-infection","display_name":"urinary tract infection","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9819999933242798},{"id":"https://openalex.org/keywords/metformin-add-on-therapy","display_name":"metformin add-on therapy","score":0.9670000076293945},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9860000014305115},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":1.0},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8080000281333923},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8817232847213745},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7083451747894287},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6534634828567505},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.6192241907119751},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.5882046222686768},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.5879428386688232},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.5198860168457031},{"id":"https://openalex.org/C77411442","wikidata":"https://www.wikidata.org/wiki/Q181100","display_name":"Urinary system","level":2,"score":0.48242172598838806},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.43873658776283264},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4310436248779297},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.42595916986465454},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.42424893379211426},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.32972949743270874},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.12539735436439514},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0830804705619812}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000091662","descriptor_name":"Genital Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D000091662","descriptor_name":"Genital Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D014552","descriptor_name":"Urinary Tract Infections","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056910","descriptor_name":"Republic of Korea","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1002/prp2.910","doi":"https://doi.org/10.1002/prp2.910","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.910","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.910","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},{"id":"pmid:35005849","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35005849","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology research & perspectives","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:8929338","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8929338/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacol Res Perspect","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:8991af22f0e94566a47375f326272b71","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8991af22f0e94566a47375f326272b71","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacology Research & Perspectives, Vol 10, Iss 1, Pp n/a-n/a (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1002/prp2.910","doi":"https://doi.org/10.1002/prp2.910","is_oa":true,"landing_page_url":"https://doi.org/10.1002/prp2.910","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/prp2.910","source":{"id":"https://openalex.org/S2764487716","display_name":"Pharmacology Research & Perspectives","issn_l":"2052-1707","issn":["2052-1707"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacology Research & Perspectives","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4206018554.pdf","grobid_xml":"https://content.openalex.org/works/W4206018554.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W2000047428","https://openalex.org/W2024372370","https://openalex.org/W2036193982","https://openalex.org/W2037587089","https://openalex.org/W2050608615","https://openalex.org/W2100796772","https://openalex.org/W2131411448","https://openalex.org/W2151345870","https://openalex.org/W2165037395","https://openalex.org/W2171049608","https://openalex.org/W2290760722","https://openalex.org/W2341326607","https://openalex.org/W2551376414","https://openalex.org/W2605280905","https://openalex.org/W2619772777","https://openalex.org/W2626411548","https://openalex.org/W2773902325","https://openalex.org/W2883001358","https://openalex.org/W2891073947","https://openalex.org/W2902044664","https://openalex.org/W2941279567","https://openalex.org/W2966426030","https://openalex.org/W3015459181","https://openalex.org/W3036816724","https://openalex.org/W3128624253"],"related_works":["https://openalex.org/W2891073947","https://openalex.org/W2619772777","https://openalex.org/W2551376414","https://openalex.org/W4224327037","https://openalex.org/W2954115740","https://openalex.org/W4413472907","https://openalex.org/W2790579026","https://openalex.org/W4206566081","https://openalex.org/W7165522627","https://openalex.org/W4380577172"],"abstract_inverted_index":{"Sodium-glucose":[0],"cotransporter-2":[1],"(SGLT-2)":[2],"inhibitors":[3,36,175,187,226],"are":[4,227],"antidiabetic":[5],"drugs":[6],"with":[7,32,45,86,121,178,230],"associated":[8,31,177,229],"safety":[9],"concerns":[10],"regarding":[11],"the":[12,23,69,117,128,134,147,156,168,217],"risk":[13,24,181,218,233],"of":[14,25,34,138,160,182,219,234],"genital":[15,26,97,183,235],"and":[16,27,59,83,98,141,151,199,236,245],"urinary":[17,28,99,220,237],"tract":[18,29,100,221,238],"infections.":[19,101,222],"This":[20],"study":[21,67],"assessed":[22,169],"infections":[30,184,239],"prescription":[33,91],"SGLT-2":[35,171,174,225],"as":[37,206],"an":[38,207],"add-on":[39,208],"therapy":[40,209],"to":[41,52,77,89,115,146,210,241],"metformin":[42],"in":[43,73,133,167],"patients":[44,131,143],"type":[46],"2":[47],"diabetes":[48],"mellitus":[49],"(T2DM)":[50],"compared":[51,240],"dipeptidyl":[53],"peptidase-4":[54],"(DPP-4)":[55],"inhibitors,":[56,149,243],"sulfonylurea":[57],"(SU),":[58],"thiazolidinedione":[60],"(TZD).":[61],"We":[62],"conducted":[63],"a":[64,122,136,179,231],"retrospective":[65],"cohort":[66],"using":[68,105,155],"NHIS-National":[70],"Health":[71],"Insurance-Database":[72],"Korea":[74],"from":[75],"2014":[76],"2017.":[78],"Patients":[79],"aged":[80],"\u226519":[81],"years":[82],"those":[84],"diagnosed":[85],"T2DM":[87],"prior":[88],"drug":[90,170],"were":[92,96,144,176,214],"enrolled.":[93],"The":[94],"outcomes":[95],"Analysis":[102],"was":[103],"performed":[104],"Cox's":[106],"proportional":[107],"hazard":[108,118],"model":[109],"following":[110],"1:1":[111],"propensity":[112,157],"score":[113,158],"matching":[114],"calculate":[116],"ratio":[119],"(HR)":[120],"95%":[123,190,196,203],"confidence":[124],"interval":[125],"(CI).":[126],"Among":[127],"107":[129],"131":[130],"included":[132],"study,":[135],"total":[137],"7738,":[139],"7145,":[140],"2175":[142],"assigned":[145],"DPP-4":[148,186,242],"SU,":[150,244],"TZD":[152,200],"comparator":[153,162],"groups,":[154],"(PS)":[159],"each":[161],"based":[163],"on":[164],"7741":[165],"people":[166],"inhibitor":[172],"group.":[173],"higher":[180,232],"than":[185],"(HR:":[188,194,201],"2.39,":[189],"CI:":[191,197,204],"2.07-2.76),":[192],"SU":[193],"3.23,":[195,202],"2.73-3.81),":[198],"2.35-4.44),":[205],"metformin.":[211],"Similar":[212],"results":[213],"observed":[215],"for":[216],"In":[223],"conclusion,":[224],"significantly":[228],"TZD.":[246]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-01-25T00:00:00"}